UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 3: Comparative assessement of prediction methods of human clearance

Journal of pharmaceutical sciences, 2011-10, Vol.100 (10), p.4090-4110

2011

Volltextzugriff (PDF)

PHRMA CPCDC initiative on predictive models of human pharmacokinetics, part 5: Prediction of plasma concentration–time profiles in human by using the physiologically‐based pharmacokinetic modeling approach

Journal of pharmaceutical sciences, 2011-10, Vol.100 (10), p.4127-4157

2011

Volltextzugriff (PDF)

PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 4: Prediction of plasma concentration–time profiles in human from in vivo preclinical data by using the Wajima approach

Journal of pharmaceutical sciences, 2011-10, Vol.100 (10), p.4111-4126

2011

Volltextzugriff (PDF)

The conduct of in vitro and in vivo drug-drug interaction studies: a Pharmaceutical Research and Manufacturers of America (PhRMA) perspective

Drug metabolism and disposition, 2003-07, Vol.31 (7), p.815-832

2003

Volltextzugriff (PDF)

PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 2: Comparative assessment of prediction methods of human volume of distribution

Journal of pharmaceutical sciences, 2011-10, Vol.100 (10), p.4074-4089

2011

Volltextzugriff (PDF)

PhRMA CPCDC Initiative on Predictive Models of Human Pharmacokinetics, Part 1: Goals, Properties of the Phrma Dataset, and Comparison with Literature Datasets

Journal of pharmaceutical sciences, 2011-10, Vol.100 (10), p.4050-4073

2011

Volltextzugriff (PDF)

Enhanced clearance of Aβ in brain by sustaining the plasmin proteolysis cascade

Proceedings of the National Academy of Sciences - PNAS, 2008-06, Vol.105 (25), p.8754-8759

2008

Volltextzugriff (PDF)

Detection of ECG effects of (2R,4R)-monatin, a sweet flavored isomer of a component first identified in the root bark of the Sclerochitin ilicifolius plant

Food and chemical toxicology, 2016-05, Vol.91, p.217-224

2016

Volltextzugriff (PDF)

A Review and Assessment of Potential Sources of Ethnic Differences in Drug Responsiveness

Journal of clinical pharmacology, 2003-09, Vol.43 (9), p.943-967

2003

Volltextzugriff (PDF)

The Conduct of In Vitro and In Vivo Drug-Drug Interaction Studies: A PhRMA Perspective

Journal of clinical pharmacology, 2003-05, Vol.43 (5), p.443-469

2003

Volltextzugriff (PDF)

Pharmacokinetics of losartan, an angiotensin II receptor antagonist, and its active metabolite EXP3174 in humans

Clinical pharmacology and therapeutics, 1995-12, Vol.58 (6), p.641-649

1995

Volltextzugriff (PDF)

Interpatient variability in bioavailability is related to the extent of absorption: Implications for bioavailability and bioequivalence studies

Clinical pharmacology and therapeutics, 1996-12, Vol.60 (6), p.601-607

1996

Volltextzugriff (PDF)

Biochemical Effects of Losartan, a Nonpeptide Angiotensin II Receptor Antagonist, on the Renin-Angiotensin-Aldosterone System in Hypertensive Patients

Hypertension (Dallas, Tex. 1979), 1995-01, Vol.25 (1), p.37-46

1995

Volltextzugriff (PDF)

Effects of Losartan on Blood Pressure, Plasma Renin Activity, and Angiotensin II in Volunteers

Hypertension (Dallas, Tex. 1979), 1993-05, Vol.21 (5), p.704-713

1993

Volltextzugriff (PDF)

Integrated Population Pharmacokinetics of Etanercept in Healthy Subjects and in Patients With Rheumatoid Arthritis Ankylosing Spondylitis

Journal of clinical pharmacology, 2011-06, Vol.51 (6), p.864-875

2011

Volltextzugriff (PDF)

The Conduct of In Vitro and In Vivo Drug-Drug Interaction Studies: A PhRMA Perspective

Journal of clinical pharmacology, 2003-05, Vol.43 (5), p.443-469

2003

Volltextzugriff (PDF)

Pharmacokinetics and erythropoietic response to human recombinant erythropoietin in healthy men

Clinical pharmacology and therapeutics, 1990-05, Vol.47 (5), p.557-564

1990

Volltextzugriff (PDF)

A Note from the Scientific Program Committee Chairperson: Submission of Abstracts for the 1993 Annual Meeting

Clinical pharmacology and therapeutics, 1992-06, Vol.51 (6), p.750-750

Bjornsson, Thorir D

1992

Volltextzugriff (PDF)

Antiplatelet Effects of MK-852, a Platelet Fibrinogen Receptor Antagonist, in Healthy Volunteers

Journal of clinical pharmacology, 2000-05, Vol.40 (5), p.496-507

2000

Volltextzugriff (PDF)

A Matrix Method for the Evaluation of Therapeutic Agents: A Framework Based on Disease Process-Oriented Mechanisms of Drug Action and Their Effectiveness

Drug information journal, 1997, Vol.31 (1), p.105-110

Bjornsson, Thorir D.

1997

Volltextzugriff (PDF)

Use of Serum Creatinine Concentrations to Determine Renal Function1

Clinical pharmacokinetics, 1979, Vol.4 (3), p.200-222

Bjornsson, Thorir D.

1979

Volltextzugriff (PDF)

Molecular cloning of the alcohol/hydroxysteroid form ( hST a ) of sulfotransferase from human liver

Biochemical and biophysical research communications, 1992-08, Vol.187 (1), p.448-454

1992

Volltextzugriff (PDF)

The method of relative drug accumulation: A simple method for illustrating the effects of different drug dosing regimens and variability in drug elimination on time courses of drug concentrations

Clinical pharmacology and therapeutics, 1992-03, Vol.51 (3), p.266-270

Bjornsson, Thorir D

1992

Volltextzugriff (PDF)

Oral dipyridamole increases plasma adenosine levels in human beings

Clinical pharmacology and therapeutics, 1989-01, Vol.45 (1), p.80-84

1989

Volltextzugriff (PDF)

The regulation of plasminogen activators and plasminogen activator inhibitor type 1 in endothelial cells by sex hormones

American journal of obstetrics and gynecology, 1995-09, Vol.173 (3), p.801-808

1995

Volltextzugriff (PDF)

1 – 25 von 102

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(101)
Mit Volltextzugriff
(60)

Publikationsform

Artikel
(102)

Sprache

Englisch
(102)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 3: Comparative assessement of prediction methods of human clearance

PHRMA CPCDC initiative on predictive models of human pharmacokinetics, part 5: Prediction of plasma concentration–time profiles in human by using the physiologically‐based pharmacokinetic modeling approach

PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 4: Prediction of plasma concentration–time profiles in human from in vivo preclinical data by using the Wajima approach

The conduct of in vitro and in vivo drug-drug interaction studies: a Pharmaceutical Research and Manufacturers of America (PhRMA) perspective

PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 2: Comparative assessment of prediction methods of human volume of distribution

PhRMA CPCDC Initiative on Predictive Models of Human Pharmacokinetics, Part 1: Goals, Properties of the Phrma Dataset, and Comparison with Literature Datasets

Enhanced clearance of Aβ in brain by sustaining the plasmin proteolysis cascade

Detection of ECG effects of (2R,4R)-monatin, a sweet flavored isomer of a component first identified in the root bark of the Sclerochitin ilicifolius plant

A Review and Assessment of Potential Sources of Ethnic Differences in Drug Responsiveness

The Conduct of In Vitro and In Vivo Drug-Drug Interaction Studies: A PhRMA Perspective

Pharmacokinetics of losartan, an angiotensin II receptor antagonist, and its active metabolite EXP3174 in humans

Interpatient variability in bioavailability is related to the extent of absorption: Implications for bioavailability and bioequivalence studies

Biochemical Effects of Losartan, a Nonpeptide Angiotensin II Receptor Antagonist, on the Renin-Angiotensin-Aldosterone System in Hypertensive Patients

Effects of Losartan on Blood Pressure, Plasma Renin Activity, and Angiotensin II in Volunteers

Integrated Population Pharmacokinetics of Etanercept in Healthy Subjects and in Patients With Rheumatoid Arthritis Ankylosing Spondylitis

The Conduct of In Vitro and In Vivo Drug-Drug Interaction Studies: A PhRMA Perspective

Pharmacokinetics and erythropoietic response to human recombinant erythropoietin in healthy men

A Note from the Scientific Program Committee Chairperson: Submission of Abstracts for the 1993 Annual Meeting

Antiplatelet Effects of MK-852, a Platelet Fibrinogen Receptor Antagonist, in Healthy Volunteers

A Matrix Method for the Evaluation of Therapeutic Agents: A Framework Based on Disease Process-Oriented Mechanisms of Drug Action and Their Effectiveness

Use of Serum Creatinine Concentrations to Determine Renal Function1

Molecular cloning of the alcohol/hydroxysteroid form ( hST a ) of sulfotransferase from human liver

The method of relative drug accumulation: A simple method for illustrating the effects of different drug dosing regimens and variability in drug elimination on time courses of drug concentrations

Oral dipyridamole increases plasma adenosine levels in human beings

The regulation of plasminogen activators and plasminogen activator inhibitor type 1 in endothelial cells by sex hormones

Suchergebnisse filtern